https://www.accesswire.com/708333/Lexarias-Human-Nicotine-Study-Nearing-Start-Date
Splunk Patent Case Vs An Ex-Employee’s Growing Firm Has Merit, Analyst Says
Raymond James analyst Adam Tindle assigned Splunk Inc (NASDAQ:SPLK) a Moderately Aggressive Risk/Wealth Accumulation (MA/ACC) rating given its fast-growing market. Splunk filed…